Scott A Canute - Net Worth and Insider Trading
Scott A Canute Net Worth
The estimated net worth of Scott A Canute is at least $21 Million dollars as of 2024-11-13. Scott A Canute is the President, Mfg. Operations of Eli Lilly and Co and owns about 26,162 shares of Eli Lilly and Co (LLY) stock worth over $21 Million. Details can be seen in Scott A Canute's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott A Canute has not made any transactions after 2005-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott A Canute
Scott A Canute Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott A Canute owns 7 companies in total, including Immunomedics Inc (IMMU) , Flexion Therapeutics Inc (FLXN) , and Akebia Therapeutics Inc (AKBA) among others .
Click here to see the complete history of Scott A Canute’s form 4 insider trades.
Insider Ownership Summary of Scott A Canute
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| IMMU | Immunomedics Inc | 2020-10-23 | director |
| FLXN | Flexion Therapeutics Inc | 2020-06-10 | director |
| AKBA | Akebia Therapeutics Inc | 2016-07-29 | director |
 | | 2015-07-21 | director |
| | 2016-05-12 | director |
| | 2005-08-15 | President & Mfg. Operations |
| | 2020-12-11 | director |
Scott A Canute Latest Holdings Summary
Scott A Canute currently owns a total of 1 stock. Scott A Canute owns 26,162 shares of Eli Lilly and Co (LLY) as of August 15, 2005, with a value of $21 Million.
Latest Holdings of Scott A Canute
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co | 2005-08-15 | 26,162 | 818.86 | 21,423,015 |
Holding Weightings of Scott A Canute
Scott A Canute Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott A Canute has made a total of 0 transactions in Eli Lilly and Co (LLY) over the past 5 years. The most-recent trade in Eli Lilly and Co is the sale of 3,200 shares on August 15, 2005, which brought Scott A Canute around $170,560.
Insider Trading History of Scott A Canute
- 1
Scott A Canute Trading Performance
Scott A Canute Ownership Network
Ownership Network List of Scott A Canute
Ownership Network Relation of Scott A Canute
Scott A Canute Owned Company Details
What does Immunomedics Inc do?
Who are the key executives at Immunomedics Inc?
Scott A Canute is the director of Immunomedics Inc. Other key executives at Immunomedics Inc include director & 10 percent owner & other: See Remarks Venbio Select Advisor Llc , director & 10 percent owner & other: See Remarks Behzad Aghazadeh , and director & President and CEO Harout Semerjian .
Immunomedics Inc (IMMU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunomedics Inc (IMMU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunomedics Inc (IMMU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunomedics Inc (IMMU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunomedics Inc Insider Transactions
Scott A Canute Mailing Address
Above is the net worth, insider trading, and ownership report for Scott A Canute. You might contact Scott A Canute via mailing address: Flexion Therapeutics, Inc., 10 Mall Road, Suite 301, Burlington Ma 01803.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
